- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Stage IIIC Non-Small Cell Lung Cancer in Korea, Republic of
Total 1097 results
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerBelgium, United States, Korea, Republic of, Taiwan, United Kingdom, Netherlands
-
Samsung Medical CenterUnknownNonsmall Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterAstraZenecaTerminatedSmall Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterTerminated
-
Samsung Medical CenterAstraZenecaTerminatedSmall Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterCompletedSmall Cell Lung CancerKorea, Republic of
-
AstraZenecaDaiichi SankyoRecruitingNon-small Cell Lung CancerGermany, Taiwan, Australia, China, Korea, Republic of
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerTaiwan, Spain, Italy, United States, Korea, Republic of, France
-
Chonnam National University HospitalChong Kun Dang PharmaceuticalCompletedCarcinoma, Small CellKorea, Republic of
-
Seoul National University HospitalCompletedSmall Cell Lung CancerKorea, Republic of
-
Novartis PharmaceuticalsTerminatedSquamous Non-small Cell Lung CancerGermany, Spain, Korea, Republic of, Belgium, Italy, United States, France, Sweden
-
Seoul National University HospitalUnknownNon Small Cell Lung Cancer PatientsKorea, Republic of
-
Novartis PharmaceuticalsRecruitingNon-small Cell Lung CancerUnited States, Korea, Republic of, Spain, Japan, Germany, Switzerland
-
National Cancer Institute (NCI)NCIC Clinical Trials Group; Cancer and Leukemia Group B; North Central Cancer... and other collaboratorsActive, not recruitingStage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7United States, Canada, Ireland, Peru, South Africa
-
Samsung Medical CenterCompletedSmall Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterCompleted
-
Gachon University Gil Medical CenterUnknownSmall Cell Lung CancerKorea, Republic of
-
Yonsei UniversityCompletedLung CancerKorea, Republic of
-
Samsung Medical CenterCompletedSmall Cell Lung CancerKorea, Republic of
-
National Cancer Center, KoreaRoche Korea co.,Ltd.RecruitingSequential Hypofractionated Radiotherapy Followed by Anti-PD-L1 Atezolizumab for SCLC (Atezolizumab)Small Cell Lung Cancer RecurrentKorea, Republic of
-
MedImmune LLCCompletedStage III Non-small Cell Lung Cancer | UnresectableUnited States, Canada, Italy, Spain, France, Hong Kong, Portugal, Taiwan, Poland
-
JI-YOUN HANNational Cancer Center, KoreaCompletedSmall Cell Lung Cancer | Small Cell Lung Cancer RecurrentKorea, Republic of
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerUnited States, Taiwan, Italy, Korea, Republic of
-
Eli Lilly and CompanyCompletedA Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung CancerNon-Small Cell Lung Cancer Stage IVUnited States, Italy, Spain, Australia, France, Germany, Hungary, Korea, Republic of, Poland, Romania, Russian Federation, Taiwan, Ukraine
-
National Cancer Institute (NCI)RecruitingAdvanced Lung Non-Small Cell Carcinoma | Recurrent Lung Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7United States
-
Novartis PharmaceuticalsCompletedNon-small-cell Lung CancerCanada, France, Spain, Netherlands, Singapore, Germany, Korea, Republic of, Turkey, United States, Norway
-
Samsung Medical CenterUnknownSmall Cell Lung CancerKorea, Republic of
-
ETOP IBCSG Partners FoundationHoffmann-La Roche; AstraZenecaActive, not recruitingNon Small Cell Lung Cancer MetastaticIreland, Singapore, Spain, Switzerland, Korea, Republic of, Netherlands
-
Konkuk University Medical CenterYuhan CorporationRecruitingNon Small Cell Lung CancerKorea, Republic of
-
Yonsei UniversityUnknownNon-DM Stage II High-risk Colorectal Cancer | Non-DM Stage III Colorectal CancerKorea, Republic of
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore
-
AstraZenecaCompletedNon Small Cell Lung CancerKorea, Republic of, Taiwan, United Kingdom, Spain, United States, Netherlands
-
National Cancer Center, KoreaRecruiting
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerChina, Hong Kong, Taiwan, Philippines, Thailand, Korea, Republic of, Indonesia
-
Samyang Biopharmaceuticals CorporationRecruitingBreast Cancer | Head and Neck Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Non-small Cell Lung CancerKorea, Republic of
-
AstraZenecaActive, not recruitingNon Small Cell Lung CancerBelgium, Korea, Republic of, Spain, United States, France
-
Samsung Medical CenterCompleted
-
National Cancer Center, KoreaUnknownCarcinoma, Non-Small-Cell Lung | Thoracic Surgery, Video-AssistedKorea, Republic of
-
Se-Hoon LeeRoche Pharma AG; AstraZenecaCompletedLung CancerKorea, Republic of
-
National Cancer Center, KoreaCompletedSmall Cell Lung CancerKorea, Republic of
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerUnited States, Argentina, China, Korea, Republic of
-
Daiichi Sankyo, Inc.CompletedAdvanced Non-small Cell Lung Cancer (NSCLC)Korea, Republic of, United States, India, Germany
-
SanofiActive, not recruitingNon-small Cell Lung Cancer MetastaticKorea, Republic of, United States, Bulgaria, Czechia, Portugal, Spain
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingNon Small Cell Lung Cancer | Nonsquamous Nonsmall Cell Neoplasm of Lung | Non Small Cell Lung Cancer Metastatic | Sensitizing EGFR Gene MutationUnited States, Korea, Republic of, Singapore, Taiwan
-
Novartis PharmaceuticalsRecruitingNon-Small-Cell Lung CarcinomaKorea, Republic of
-
Hoffmann-La RocheActive, not recruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Spain, Switzerland, Australia
-
National Cancer Center, KoreaPfizer; Roche Pharma AGUnknownNSCLC | Lung CancerKorea, Republic of
-
Samsung Medical CenterRecruitingNeuroendocrine Carcinoma | Small Cell Lung CancersKorea, Republic of
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Platinum-resistant Ovarian Cancer | Locally Advanced Solid Tumor | Post Anti-PD-1 Melanoma | 2L+ Cervical Cancer | Neoadjuvant Melanoma | Neoadjuvant Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Small Cell...United States, Australia, Korea, Republic of
-
Merck Sharp & Dohme LLCRecruitingNon Small Cell Lung CancerUnited States, Israel, Taiwan, Korea, Republic of, Switzerland, Hong Kong